In February, Illumina announced it would be laying off 96 San Diego workers.

Pfizer sold the five-building facility on Science Center Drive in Torrey Pines to BioMed Realty, a San Diego-based firm owned ...

Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant’s bid to win a slice of ...

UC San Diego’s Moores Cancer Center has received a $1 million donation from pharmaceutical giant Pfizer to support early cancer detection, it was announced Thursday. The Moores Center will use ...

BioMed Realty has made a big long-term bet on demand in San Diego’s life science sector with a $255M acquisition of Pfizer’s sprawling research campus in the city. The five-building office ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

Medicinal chemists revealed the structures of a dozen clinical candidates during the “First-Time Disclosures” symposium on March 26 at the American Chemical Society Spring 2025 meeting in San ...